Skip to content

Trevi Therapeutics, Inc. TRVI Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

BancFirst Corporation logo
BancFirst CorporationBANF
$10.78M-4.7%
First BanCorp logo
First BanCorpFBP
$5.17M+248%
ePlus logo
ePlusPLUS
$1.18M-36.5%
TFS Financial logo
TFS FinancialTFSL
$4.25M-38.9%
The Bancorp logo
The BancorpTBBK
$468K-38.8%
Columbia Financial, Inc. logo
Columbia Financial, Inc.CLBK
$1.87M-35.7%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.49B+152%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s payments to acquire property, plant, and equipment?
Trevi Therapeutics, Inc. (TRVI) reported payments to acquire property, plant, and equipment of $102K in Q1 2026.
What does payments to acquire property, plant, and equipment mean?
Measures the cash expenditures directed toward the acquisition or construction of long-term physical assets, such as laboratory equipment or facilities. It is a key indicator of the company's investment in its infrastructure and future operational capacity.